CNTNNasdaqFinance ServicesFiscal year ends December 31
Canton Strategic Holdings, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026
$1.69−0.01 (-0.29%)
Close on Oct 19, 2026
- Market cap
- $366.50M
- P/E (TTM)
- –
- Dividend yield
- –
Canton Strategic Holdings, Inc. revenue by segment
By business segment
| Operating income | FY2025 | FY2024 | YoY |
|---|---|---|---|
| Digital Asset Treasury [Member] | -$2.77M | – | – |
| Clinical Stage Bio Technology [Member] | -$17.34M | -$12.43M | +39.5% |
By product or service
By region
From the segment and revenue-disaggregation notes of Canton Strategic's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.